ICD-10-PCS 2027 procedure code
XW043MAIntroduction of Emapalumab-lzsg Anti-IFNy Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 10
Short description: Introduce Emapalumab-lzsg in Central Vein, Perc, New Tech 10
Code last changed in FY2026 (effective October 1, 2025). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About XW043MA
XW043MA is the ICD-10-PCS code for a introduction procedure on the central vein using a percutaneous approach with emapalumab-lzsg anti-ifny monoclonal antibody (qualifier: new technology group 10). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
For a different body part, codes include XW033MA (peripheral vein).
With a different device, use XW0433A (maribavir anti-infective), XW0434A (stem cells, somatic), XW0435A (ifezuntirgene inilparvovec), XW0438A (mineral-based topical hemostatic agent), XW0439A (odronextamab antineoplastic), XW043BA (vancomycin-eluting bone void filler) and 3 more.
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It was added in FY2026, effective October 1, 2025.
What each character means
- 1. Section
- XNew Technology
- 2. Body System
- WAnatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body Part
- 4Central Vein
- 5. Approach
- 3Percutaneous
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
- 6. Device / Substance / Technology
- MEmapalumab-lzsg Anti-IFNy Monoclonal Antibody
Includes: GAMIFANT(R)
- 7. Qualifier
- ANew Technology Group 10
Other versions of this procedure
Different body part
Different device / substance / technology
- XW0433AMaribavir Anti-infective
- XW0434AStem Cells, Somatic
- XW0435AIfezuntirgene Inilparvovec
- XW0438AMineral-based Topical Hemostatic Agent
- XW0439AOdronextamab Antineoplastic
- XW043BAVancomycin-eluting Bone Void Filler
- XW043CARecombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold
- XW043FAOther New Technology Therapeutic Substance
- XW043NASER-109
Different qualifier
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2026 (effective 10/1/2025): Added
- No changes since FY2026.
Common questions about XW043MA
Is XW043MA a valid ICD-10-PCS code for 2027?
- Yes. XW043MA is valid for inpatient procedures from October 1, 2026 through September 30, 2027.